China Resources Medical Clarifies Board and Committee Roles in Governance Update

China Resources Medical Holdings Co ( (HK:1515) ) has provided an announcement.

China Resources Medical Holdings has disclosed the full composition of its board of directors, naming four executive directors, one non-executive director and four independent non-executive directors, with Yu Hai serving as chairman and Zhang Chuang as chief executive officer. The board also outlined the structure of its three key governance committees, detailing chairmanships and memberships for the audit, nomination and remuneration committees, signalling a clear allocation of oversight responsibilities to support corporate governance and stakeholder confidence.

The audit committee will be chaired by independent director Fu Tingmei, while the nomination committee will be led by independent director Wu Ting Yuk, Anthony, and the remuneration committee by Yu Hai, consolidating independent oversight in areas critical to risk, leadership selection and pay. This refreshed disclosure of committee roles clarifies accountability across the board, potentially strengthening transparency, risk management and alignment with investor expectations on governance standards in the PRC healthcare sector.

The most recent analyst rating on (HK:1515) stock is a Sell with a HK$3.00 price target. To see the full list of analyst forecasts on China Resources Medical Holdings Co stock, see the HK:1515 Stock Forecast page.

More about China Resources Medical Holdings Co

China Resources Medical Holdings Company Limited is a healthcare services provider based in the People’s Republic of China and listed in Hong Kong under stock code 1515. The company operates within the medical and hospital services industry, with governance overseen by a board comprising executive, non-executive and independent non-executive directors.

Average Trading Volume: 6,068,905

Current Market Cap: HK$3.98B

For detailed information about 1515 stock, go to TipRanks’ Stock Analysis page.